FZMD Stock — Fuse Medical, Inc.: Metrics

Market overview

2 metrics

Share price

$0.03

Market cap

$2.22M

Price action

19 metrics

Price change (1W)

+21.7%

Price change (30D)

+40.0%

Price change (3M)

—

Price change (6M)

-30.0%

Price change (YTD)

+40.0%

Price change (1Y)

-72.0%

Trailing year

Price change (5Y)

-83.5%

52-week high

$0.10

52-week low

$0.02

Change from 52-week high

-72.0%

Change from 52-week low

+40.0%

Annualized volatility

—

Beta

—

RSI (14D)

46.1

Price vs SMA 50

-36.4%

Price vs SMA 200

-73.6%

Avg volume (3M)

—

Relative volume

—

Average dollar volume

—

Company

3 metrics

Sector

Healthcare

Industry

Medical Devices

Shares outstanding

73.90M

Valuation

12 metrics

P / E (TTM)

0.6

Trailing earnings · reciprocal yield 179.4%

PEG ratio

—

EV / revenue

—

EV / EBITDA

—

EV / EBIT

—

P / sales

0.1×

reciprocal yield 830.2%

P / book

—

FCF yield

—

TTM · current market cap

Buyback yield

—

P / FCF

—

P / operating cash flow

118.9

reciprocal yield 0.8%

Earnings yield

179.4%

Historical valuation

8 metrics

P / E historical average (3Y)

—

P / E historical average (5Y)

—

EV / revenue historical average (3Y)

—

EV / revenue historical average (5Y)

—

EV / EBIT historical average (3Y)

—

EV / EBIT historical average (5Y)

—

EV / EBITDA historical average (3Y)

—

EV / EBITDA historical average (5Y)

—

Dividends & buybacks

7 metrics

Dividend yield

—

Trailing 12 months

Payout ratio

—

Shareholder yield

—

Dividend / share (TTM)

—

Dividend growth YoY

—

Dividend growth streak

—

Last ex-dividend

—

Earnings calendar

2 metrics

Next earnings

—

Last earnings

—

Profitability

9 metrics

Gross margin

65.6%

Operating margin

-0.7%

Trailing 12 months

Net margin

21.6%

Gross profit (TTM)

$12.07M

Operating profit (TTM)

−$121,583

Net income (TTM)

$3.98M

Trailing 12 months

Diluted EPS (TTM)

—

FCF margin

—

Effective tax rate

0.7%

Per share

11 metrics

Revenue per diluted share (TTM)

—

Gross profit per diluted share (TTM)

—

Operating profit per diluted share (TTM)

—

EBITDA per diluted share (TTM)

—

Net income per diluted share (TTM)

—

Operating cash flow per diluted share (TTM)

—

Free cash flow per diluted share (TTM)

—

Capital expenditures per diluted share (TTM)

—

R&D per diluted share (TTM)

—

Stock compensation per diluted share (TTM)

—

Book value per share

$0.01

Growth

11 metrics

Revenue growth YoY

+7.0%

Year over year

Net income growth YoY

—

Revenue (TTM)

$18.40M

Trailing 12 months

EPS growth YoY

—

Shares change YoY

+10.7%

Year over year · more shares

Revenue CAGR (3Y)

-6.6%

Revenue CAGR (5Y)

-6.7%

EPS CAGR (3Y)

—

EPS CAGR (5Y)

+0.0%

FCF CAGR (3Y)

-48.5%

FCF CAGR (5Y)

—

Quality

14 metrics

Return on equity

—

Return on assets

20.6%

Debt / equity

—

Current ratio

1.1

EBITDA (TTM)

—

Free cash flow (TTM)

—

Quick ratio

0.3

Interest coverage

-0.6

Net debt / EBITDA

—

Return on invested capital

—

Trailing 12 months

Net cash

—

Latest balance sheet

Cash & equivalents

$253,378

Total assets

$19.32M

Total debt

$100,000

Cash flow & spend

7 metrics

Operating cash flow (TTM)

$18,641

Capital expenditures (TTM)

—

R&D (TTM)

—

SG&A (TTM)

$6.73M

Stock compensation (TTM)

$22,852

R&D / revenue

—

Stock compensation / revenue

—

Ownership (13F)

3 metrics

13F filers

—

13F filer change QoQ

—

Institutional ownership

—

Short interest

3 metrics

Short interest

—

Latest settlement

Days to cover

—

Short-squeeze score

—

Insider activity

2 metrics

Net insider buying (90D)

—

Insider-sentiment score

—

Risk flags

1 metrics

Going concern

—

FZMD · Fuse Medical, Inc.

FZMD metrics

Market overview

Price action

Company

Valuation

Historical valuation

Dividends & buybacks

Earnings calendar

Profitability

Growth

Quality

Cash flow & spend

Ownership (13F)

Short interest

Insider activity

Risk flags

No metrics match that search